A kind of preparation method of cefditoren pivoxil
By using a functionalized ionic liquid [PEMIm][PbCl3] catalyst to prepare ceftriaxone under mild conditions, the problems of low yield, low purity and high cost in the existing technology have been solved, and efficient and environmentally friendly industrial production has been achieved.
Patent Information
- Application Number
- CN202411189008.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2044-08-28
AI Technical Summary
Existing methods for preparing ceftriaxone suffer from problems such as long reaction routes, low yields, low purity, expensive reagents, and are not conducive to industrialization.
The functionalized ionic liquid [PEMIm][PbCl3] was used as a catalyst and solvent to carry out the condensation reaction of 7-ATCA and AE-active ester under mild conditions, and then reacted with methyl tervastatin to prepare ceftriaxone. The ionic liquid can be reused, reducing post-treatment steps and wastewater generation.
It improves the yield and purity of ceftriaxone, reduces production costs, simplifies the process, meets green and environmental protection requirements, and is suitable for industrial production.
Smart Images

Figure SMS_1 
Figure QLYQS_1 
Figure QLYQS_2
Abstract
Description
Technical Field
[0001] The invention relates to the field of organic synthesis, and in particular to a method for preparing cefditoren pivoxil. Background Art
[0002] Cefditoren pivoxil, whose chemical name is (-)-(6R,7R)-2,2-dimethylpropionyloxymethyl 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, is an ester-type oral third-generation cephem antibiotic developed by Meiji Co., Ltd. of Japan and was first launched in Japan in 1994. This product has a wide range of antibacterial effects, especially against gram-positive bacteria such as Staphylococcus, Streptococcus (including Streptococcus pneumoniae), gram-negative bacteria such as Escherichia coli, Branella catarrhalis, Klebsiella, Proteus, Haemophilus influenzae, and anaerobic bacteria such as Peptostreptococcus and Bacteroides. Its antibacterial ability is superior to that of existing cephems. The mechanism of action of this drug is to inhibit bacterial cell wall synthesis. It has the characteristics of a wide antibacterial spectrum, significant efficacy, safety and stability, good oral absorption, high blood drug concentration, and wide distribution in the body. It is widely used in clinical practice.
[0003]
[0004] The main methods for preparing cefditoren pivoxil in the prior art are as follows:
[0005] 7-aminocephalosporanic acid (7-ACA) is used as a raw material, and 7-amino-3-hydroxymethylcephalosporanic acid (7-AHCA) is obtained by hydrolysis, and then acylated with 2-methoxyimino-2-(2-amino-4-thiazolyl) benzothiazolyl thioacetate (AE active ester), esterified with iodomethyl pivalate to introduce the C-4 side chain, and then reacted with triphenylphosphine through chlorination, iodination to obtain Wittig reagent, and finally reacted with 4-methyl-5-thiazole aldehyde to introduce the C-3 side chain to obtain the target product. The reaction route of this method is long, and the reaction process and post-treatment are complicated, and the overall yield is not high.
[0006] Another method is to react the cefditoren nucleus 7ATCA with AE-active ester to obtain cefditoren acid, and then to obtain cefditoren salt through salt formation reaction; cefditoren salt is reacted with iodine methyl pivalate to obtain cefditoren pivoxil, but the purity of the product obtained by this reaction is unstable. Researchers have made a series of improvements to this method.
[0007] CN103665002A discloses that 7-amino-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid and 2-methoxyimino-2-(2-amino-4-thiazolyl)-(z)-thioacetic acid benzothiazolyl ester (AE active ester) are used as starting materials, and cefditoren pivoxil is obtained through condensation and esterification reaction. In the esterification process, lithium salt is used instead of sodium salt, which overcomes the disadvantages of poor selectivity and low yield of the esterification reaction, improves the reaction yield, and the yield of the esterification step can reach 94.7%. CN104513256A discloses that the cefditoren mother nucleus 7ATCA is reacted with AE-active ester under alkaline conditions and 0°C-5°C, extracted with pure water, and sodium isooctanoate / acetone solution is added to obtain cefditoren sodium; cefditoren sodium is reacted with iodomethyl pivalate under alkaline conditions and -40°C to obtain a cefditoren pivoxil solution. The document uses dichloromethane as a solvent in step one, and the obtained cefditoren sodium intermediate has high purity, which avoids the generation of subsequent impurities and improves the purity of the product. At the same time, the esterification reaction is carried out at a lower temperature, which reduces the amount of iodomethyl pivalate. CN105175432A replaces the sodium salt of cefditoren acid with the ammonium salt of cefditoren acid, thereby overcoming the disadvantages of the sodium salt being difficult to store and having poor stability, and effectively removing the isomer of the E configuration; at the same time, the temperature of the subsequent esterification reaction can be reacted at -15 to -20°C, thereby reducing the possibility of acylation and alkylation reactions between the primary amine group of cefditoren acid and iodomethyl pivalate, and making the product higher in purity.
[0008] CN108084212A discloses a method for preparing cefditoren pivoxil. The method uses 7-ACA as a starting material, undergoes iodination and Wittig reactions after silylation protection, and uses an ionic liquid as a catalyst to avoid the generation of cefditoren pivoxil E isomer; ethyl aminothioxamate is used instead of AE active ester to avoid the generation of the toxic compound 2-mercaptobenzothiazole, and trimethylaluminum is used as a catalyst to increase the reaction activity; in the reaction process with methyl pivalate, the amine group is protected, and a phase transfer catalyst is used to prepare cefditoren pivoxil.
[0009] CN105732664A discloses that TMEDA (tetramethylethylenediamine) and sodium phosphate are added to the reaction system of 7-ATCA and AE-active ester, which can be used as a buffer to ensure a stable reaction environment and improve the reaction yield and purity.
[0010] A large number of methods for preparing cefditoren pivoxil are disclosed in the prior art, but there are still problems such as low product purity, expensive reaction reagents, complicated process flow, and being unfavorable for industrialization. Therefore, it is of great economic value to develop a method for preparing cefditoren pivoxil suitable for industrialization. Summary of the invention
[0011] In order to solve the above technical problems existing in the prior art, the present invention provides a method for preparing cefditoren pivoxil. The method of the present invention has mild reaction conditions, the reaction catalyst can be recycled, energy saving and environmental protection, and is more suitable for industrial production.
[0012] The present invention provides a method for preparing cefditoren pivoxil, which is characterized by comprising the following steps:
[0013] 1) In the presence of functionalized ionic liquid, 7-ATCA is reacted with AE-active ester to prepare intermediate 1;
[0014] 2) Intermediate 1 reacts with chloromethyl pivalate to obtain cefditoren pivoxil;
[0015] The reaction route is as follows:
[0016] ;
[0017] Wherein: the functionalized ionic liquid is selected from [PEMIm] [PbCl 3 ].
[0018] Preferably, the reaction solution of step 1) of the present invention does not need to be post-treated and can be directly subjected to the reaction of step 2).
[0019] Preferably, the reaction temperature of step 1) is -30°C to 60°C, more preferably 10°C to 40°C.
[0020] Preferably, the reaction time of step 1) is 0.5-4 hours, more preferably 1-3 hours, most preferably 2-2.5 hours.
[0021] Preferably, in step 1), the molar ratio of 7-ATCA to AE-active ester is 1:1.0-1.5, more preferably 1:1.05-1.2.
[0022] Preferably, in step 1), the mass ratio of 7-ATCA to the functionalized ionic liquid is 1:5-100, more preferably 1:10-20.
[0023] Preferably, the molar ratio of chloromethyl pivalate in step 2) to 7-ATCA in step 1) is 1-3:1, more preferably 1.1-1.5:1.
[0024] Preferably, the reaction temperature of step 2) is -20°C to 40°C, more preferably 15°C to 30°C.
[0025] Preferably, the reaction time of step 2) is 15 minutes to 3 hours, more preferably 1 hour to 2 hours.
[0026] In the process of preparing cefditoren pivoxil using 7-ATCA and AE-active ester in the prior art, since the raw materials are all multifunctional compounds, and the raw materials contain sensitive groups such as large strain heterocycles and O-methyl oximes, in the existing method for preparing cefditoren pivoxil, it is often by simply adding conventional bases to induce active thioesters and amino groups to undergo aminolysis reaction, without considering other group stability factors, resulting in complex reactions, increased by-products, and thus a low yield, and in the subsequent steps after treatment, multiple post-treatments decompose the compound again, ultimately resulting in low purity and yield of cefditoren pivoxil, and difficult purification process. CN105732664A discloses the use of TMEDA and sodium phosphate as a buffer solution to ensure the stability of the reaction environment, promote 7-ATCA and AE-active esters to generate the product cefditoren acid direction, without causing the product to decompose or a large number of side reactions. However, a large amount of TMEDA and sodium phosphate are required in the reaction process, and these two raw materials cannot be recycled, resulting in increased production costs.
[0027] In recent years, the unique solvent properties of ionic liquids have made them widely used in the fields of synthesis and catalysis. However, the economic problems and possible environmental friendliness of ionic liquids have gradually made people turn their attention to the catalytic properties of ionic liquids themselves. People have designed various functionalized ionic liquids with specific catalytic properties by modifying the structure of ionic liquids. Functionalized ionic liquids have been widely used in catalyzing carbon-nitrogen bond formation reactions. Functionalized ionic liquids usually have certain functional groups in their structures that make them catalytically active. These specific functional groups enable functionalized ionic liquids to activate reactants in a specific way.
[0028] On this basis, the inventors have found through a lot of work that in the presence of the functionalized ionic liquid of the present invention, the condensation reaction of step 1) can be achieved under relatively mild conditions, and the yield and purity of the product are both high. The ionic liquid of the present invention, as a catalyst, can not only activate the amino group in 7-ATCA, but also simultaneously activate the AE-active ester, thereby being able to play a good catalytic role. In addition, since the functionalized ionic liquid of the present invention has both acidic and alkaline properties, it can play a buffering effect, while ensuring the smooth progress of the reaction, it can also reduce the reaction by-products and improve the purity of the product. The ionic liquid of the present invention can be used as both a catalyst of step 1) and a solvent of step 1), and thus no solvent needs to be added, thereby saving costs; at the same time, since no solvent is needed, the generation of wastewater in the post-treatment process is also reduced, meeting the requirements of green environmental protection.
[0029] In addition, in the subsequent step 2) of the esterification reaction, the prior art generally requires the addition of a base catalyst, while the functionalized ionic liquid of the present invention is specifically acidic and alkaline, and can therefore be directly used as a catalyst and solvent for the esterification reaction. Therefore, there is no need to separate the product of step 1), and chloromethyl pivalate can be directly added to react to obtain cefditoren pivoxil, which greatly reduces the post-processing steps.
[0030] The ionic liquid of the invention is easy to separate and can be reused after simple activation, thus saving production costs and being conducive to industrial production. DETAILED DESCRIPTION
[0031] The following examples are provided to illustrate the present invention in detail. The following examples are provided to better illustrate the present invention and are not intended to limit the scope of the present invention. The materials, reagents, etc. used in the following examples, unless otherwise specified, can be obtained from commercial sources.
[0032] Therefore, before describing the present invention in detail, it should be understood that the present invention is not limited to the system or process parameters of specific examples which may vary of course. It should also be understood that the terms used herein are only for the purpose of describing a specific embodiment of the present invention, and are not intended to limit the scope of the present invention in any way. The examples used anywhere in this specification (including examples of any term discussed herein) are merely illustrative and in no way limit the scope and meaning of the present invention or any illustrative term. Similarly, the present invention is not limited to the various embodiments given in this specification. Unless otherwise defined, all technical and scientific terms used herein have the same meanings as those of ordinary skill in the art to which the present invention belongs. In the event of a conflict, this document (including definitions) shall prevail.
[0033] The ionic liquid [PEMIm] [PbCl 3 ], prepared with reference to the non-patent literature "Catal. Today, 2010, 158: 279-285", and its structural formula is as follows: .
[0034] Example 1
[0035] Step 1): 7-ATCA (32.3 g, 100 mmol) was added to a three-necked flask, followed by 160 g of ionic liquid [PEMIm] [PbCl 3 ], because the ionic liquid has a certain viscosity, a mechanical stirring device is required to stir for 20 minutes to completely dissolve 7-ATCA. Then, AE-active ester (38.5 g, 110 mmol) is added in three batches. The reaction is continued under stirring at room temperature for 1 hour. According to gas phase detection, the reaction of 7-ATCA in the reaction liquid is basically complete.
[0036] Step 2): Add chloromethyl pivalate (16.5 g, 110 mmol) to the reaction solution of step 1) and continue stirring the reaction for 1 hour.
[0037] After the reaction was completed, the reaction solution was poured into water, saturated ammonium chloride solution was added to adjust the pH to about 5.0, and the mixture was filtered. The filter cake was recrystallized in methanol to obtain cefditoren pivoxil, which was vacuum dried to obtain 57.4 g of a white solid with a yield of 92.6%. The purity was 98.5% as determined by HPLC.
[0038] ESI-MS(m / z): 621[M+H] + ; 1 H NMR (400 MHz, DMSO-d 6 ): 1.09(s, 9H), 2.47(s,3H), 3.48(d, 1H), 3.59(d, 1H), 3.87(s, 3H), 5.35(d, 1H), 5.75(d, 1H), 5.82(d,1H), 5.97(dd, 1H), 6.38(d, 1H), 6.79(d, 1H), 6.85(s, 1H), 7.28(s, 2H), 8.96(s, 1H), 9.72(d, 1H).
[0039] The filtrate after filtration is heated to remove most of the water, and the residue is dried in an oven to obtain the ionic liquid [PEMIm][PbCl 3 ] and can be recycled continuously, or the residue can be filtered, removed by activated carbon adsorption, and then recycled.
[0040] Example 2
[0041] Step 1): 7-ATCA (32.3 g, 100 mmol) was added to a three-necked flask, followed by 160 g of ionic liquid [PEMIm] [PbCl 3 ], because the ionic liquid has a certain viscosity, a mechanical stirring device is required to stir for 20 minutes to completely dissolve 7-ATCA. Then, AE-active ester (38.5 g, 110 mmol) is added in three batches. The reaction is continued under stirring at room temperature for 1 hour. According to gas phase detection, the reaction of 7-ATCA in the reaction liquid is basically complete.
[0042] Step 2): The reaction solution of step 1) was cooled to 10°C, chloromethyl pivalate (16.5 g, 110 mmol) was added to the reaction solution of step 1), and the reaction was continued with stirring for 2 hours.
[0043] After the reaction was completed, the reaction solution was poured into water, saturated ammonium chloride solution was added to adjust the pH to about 5.0, and the mixture was filtered. The filter cake was recrystallized in methanol to obtain cefditoren pivoxil, which was vacuum dried to obtain 55.3 g of a white solid with a yield of 89.0%. The purity was 99.3% as determined by HPLC.
[0044] The filtrate after filtration is heated to remove most of the water, and the residue is dried in an oven to obtain the ionic liquid [PEMIm][PbCl 3 ] and can be recycled continuously, or the residue can be filtered, removed by activated carbon adsorption, and then recycled.
[0045] Compared with Example 1, it can be seen that when the reaction temperature of step 2) is lowered, due to the low reactivity of chloromethyl pivalate, a longer reaction time is required, and the reaction yield is also reduced, but the product purity is improved, which may be because the occurrence of side reactions is reduced when the temperature is lowered.
[0046] Example 3
[0047] Step 1): 7-ATCA (32.3 g, 100 mmol) was added to a three-necked flask, followed by 200 g of ionic liquid [PEMIm] [PbCl 3 ], because the ionic liquid has a certain viscosity, it is necessary to use a mechanical stirring device, heat to 40 ° C and stir for 15 minutes to completely dissolve 7-ATCA. Then, AE-active ester (42.0 g, 120 mmol) was added in three batches. After the addition, the mixture was stirred and reacted for 40 minutes. According to gas phase detection, the reaction of 7-ATCA in the reaction liquid was basically completed.
[0048] Step 2): After the reaction solution was cooled to room temperature, chloromethyl pivalate (18.0 g, 120 mmol) was added to the reaction solution of step 1), and the reaction was continued with stirring for 1 hour.
[0049] After the reaction was completed, the reaction solution was poured into water, saturated ammonium chloride solution was added to adjust the pH to about 5.0, filtered, and the filter cake was recrystallized in methanol to obtain cefditoren pivoxil, which was vacuum dried to obtain 58.2 g of a white solid with a yield of 93.7%. The purity was 98.0% as determined by HPLC.
[0050] The filtrate after filtration is heated to remove most of the water, and the residue is dried in an oven to obtain the ionic liquid [PEMIm][PbCl 3 ] and can be recycled continuously, or the residue can be filtered, removed by activated carbon adsorption, and then recycled.
Claims
1. A method for preparing cefditoren pivoxil, Features The steps include: 1) In the presence of functionalized ionic liquid, 7-ATCA is reacted with AE-active ester to prepare intermediate 1; 2) Intermediate 1 reacts with chloromethyl pivalate to obtain cefditoren pivoxil; The reaction route is as follows: ; Wherein: the functionalized ionic liquid is selected from [PEMIm] [PbCl 3 ], the [PEMIm] [PbCl 3 The structural formula of ] is as follows: ; Furthermore, the reaction solution of step 1) does not need to be post-treated and can be directly subjected to the reaction of step 2).
2. The preparation method according to claim 1, Features: The reaction temperature of step 1) is 10°C to 40°C.
3. The preparation method according to claim 1 or 2, Features: The reaction time of step 1) is 1-3 hours.
4. The preparation method according to claim 1 or 2, Features: In step 1), the molar ratio of 7-ATCA to AE-active ester is 1:1.0-1.
5.
5. The preparation method according to claim 1 or 2, Features: In step 1), the mass ratio of 7-ATCA to the functionalized ionic liquid is 1:5-100.
6. The preparation method according to claim 1 or 2, Features: The molar ratio of chloromethyl pivalate in step 2) to 7-ATCA in step 1) is 1-3:
1.
7. The preparation method according to claim 1 or 2, Features: The reaction temperature of step 2) is -20°C to 40°C.
8. The preparation method according to claim 1 or 2, Features: The reaction time of step 2) is 15 minutes to 3 hours.
Citation Information
Patent Citations
Preparation method of cefditoren pivoxil
CN103665002A
Preparation method of cefditoren pivoxil
CN104513256A
Preparation method of cefditore
CN105175432A
Method for preparing cefditoren pivoxil cephalosporins
CN105732664A
Preparation method of Cefditoren Pivoxil
CN108084212A
